Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.31 | 2e-08 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.3 | 3e-08 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.28 | 6e-06 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-05 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-05 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.27 | 7e-05 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-05 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.23 | 9e-05 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0002 |